Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis

ABSTRACT Paramagnetic rim lesions (PRLs) are a subset of chronic active multiple sclerosis (MS) lesions marked by iron‐laden microglia and macrophages. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, suppresses acute MS activity, but its effect on PRLs remains unclear. In a longitudinal...

Descripció completa

Dades bibliogràfiques

Autors principals:	Kimberly H. Markowitz, Neha V. Safi, Iliana Pliska‐Bloch, Ulrike W. Kaunzner, Ha Luu, Mert Sisman, Yi Wang, Thanh D. Nguyen, Sandra Hurtado Rúa, Susan A. Gauthier
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2026-07-01
Col·lecció:	Annals of Clinical and Translational Neurology
Matèries:	multiple sclerosis ocrelizumab quantitative susceptibility mapping
Accés en línia:	https://doi.org/10.1002/acn3.70357
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!